Option Care Health (NASDAQ: OPCH) recently received a number of ratings updates from brokerages and research firms:
- 10/20/2026 – Option Care Health was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
- 10/12/2026 – Option Care Health was given a new $32.05 price target by Morgan Stanley.
- 10/9/2026 – Option Care Health was downgraded by UBS Group from “buy” to “neutral”. They now have a $32.05 price target on the stock, down from $39.00.
- 10/7/2026 – Option Care Health was given a new $32.05 price target by Truist Financial.
- 10/7/2026 – Option Care Health was downgraded by Truist Financial from “strong-buy” to “hold”.
- 10/7/2026 – Option Care Health had its “neutral” rating reaffirmed by JPMorgan Chase & Co.. They now have a $33.00 price target on the stock.
- 10/7/2026 – Option Care Health was downgraded by Citizens Jmp from “market outperform” to “hold”.
- 10/7/2026 – Option Care Health was downgraded by Barrington Research from “outperform” to “hold”.
- 10/6/2026 – Option Care Health was downgraded by Jefferies Financial Group from “buy” to “hold”. They now have a $32.05 price target on the stock, up from $28.00.
- 10/6/2026 – Option Care Health was downgraded by William Blair from “outperform” to “market perform”.
- 9/22/2026 – Option Care Health had its “buy” rating reaffirmed by UBS Group.
- 9/11/2026 – Option Care Health was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
- 8/27/2026 – Option Care Health was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.
Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.
Read More
- Five stocks we like better than Option Care Health
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Option Care Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.
